A study of clinical profile and outcome in children with dilated cardiomyopathy
DOI:
https://doi.org/10.18203/2349-3291.ijcp20233231Keywords:
Dilated cardiomyopathy, Heart failure, 2-D echocardiography, Heart transplantationAbstract
Background: Objective was to analyse the clinical profile of children diagnosed with Dilated cardiomyopathy and to correlate the same with the severity and functional status on 2-D echocardiography.
Methods: It was a prospective, retrospective and observational study. A total of 150 subjects were selected from patients visiting the cardiology OPD, admitted in medical wards, paediatric Intensive Care Unit of a tertiary care referral centre. The demographic profile, symptomatology, heart functions and compliance were recorded. The cases were evaluated by detailed history, general and cardiovascular examination and laboratory investigations along with 2D echocardiography.
Results: The demographic profile is significant as the age at diagnosis predicts the risk of mortality with older children having the worst outcome. A significant association observed between decreasing ejection fraction and increasing mortality with a p value (p=0.02). Signs of pedal edema and hepatomegaly are associated with unfavourable outcome with a significant p value of (p=0.03). The overall prognosis of children with Dilated cardiomyopathy steadily improved with timely use of appropriate medications. Only 1 patient in this study had undergone orthotopic heart transplant at the age of 15 years (case of chemotherapy induced Dilated cardiomyopathy).
Conclusions: Dilated cardiomyopathy is a difficult entity to treat in children as most cases are idiopathic and the therapy remains mostly supportive. Hypovitaminosis-D and hypocalcemia are common treatable causes of dilated cardiomyopathy in children and must be ruled out in all cases of dilated cardiomyopathy. Patients refractory to medical therapy should be considered for ventricular assist devices and orthotopic heart transplantation.
References
Daubeney PEF, Nugent AW, Chondros P. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population study. Circulation. 2006; 114:2671-8.
Bostan OM, Cil E. Dilated cardiomyopathy in childhood: Prognostic features and outcome. Acta Cardiol. 2006;61:169-74.
Singh TP, Sleeper LA, Lipshultz SE. Association of left ventricular dilation at listing for heart transplant with post-listing and early post-transplant mortality in children with dilated cardiomyopathy. Circ Heart Fail. 2009;2(6):591-8.
Jain V, Kannan L, Kumar P. Congenital hypopituitarism presenting as dilated cardiomyopathy in a child. J Pediatr Endocrinol Metab. 2011;24(9):767-9.
Baig MK, Goldman JH, Caforio AL, Coonar AS, Keeling PJ, McKenna WJ. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol. 1998;31:195-201.
Harmon WG, Sleeper LA, Cuniberti L, Messere J, Colan SD, Orav EJ, et al. Treating children with idiopathic dilated cardiomyopathy. Circ Heart Fail. 2009;104(2):281-6.
Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: Prognostic indicators and outcome. Pediatrics. 1998; 101:369-76.
Alvarez JA, Wilkinson JD, Lipshultz SE. Outcome predictors for pediatric dilated cardiomyopathy: a systematic review. J Am Coll Cardiol. 2007;23(1):25-32.
Daubeney PEF, Nugent AW, Chondros P, et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population study. Circulation. 2006;114:2671-8.
Simon M, Kormos R, Murali S, Nair P, Heffernan M, Gorcsan J, et al. Myocardial recovery using ventricular assist devices. prevalence, clinical characteristics and outcomes. Acta Cardiol. 2005;112: 32-6.
Azhar AS. Pediatric idiopathic dilated cardiomyopathy: a single centre experience. J Pediatr Endocrinol Metab. 2013;4(1):145-8.
Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:77-82.
Tsirka AE, Trinkaus K, Chen SC. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 2004;44:391-7.
Kosecik M, Ertas T. Dilated cardiomyopathy due to nutritional vitamin D deficiency rickets. Pediatr Int. 2007;49:397-9.
Van den Berg MP, van Spaendonck-Zwarts KY, van Veldhuisen DJ, Gietema JA, Postma A, van Tintelen JP. Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?. Eur J Heart Fail. 2010;12:1297-9.
Lewis A. Prognostic value of echocardiography in children with dilated cardiomyopathy. Am Heart J. 1994.
